TFF Group (TFFP)

TFF Pharmaceuticals Revenue

In the fiscal year ending April 30, 2026, TFF Pharmaceuticals had annual revenue of 312.75M EUR, down -26.49%. TFF Pharmaceuticals had revenue of 131.83M in the half year ending April 30, 2026, a decrease of -40.70%.

• Revenue (ttm): 312.75M EUR
• Revenue Growth: -26.49%
• P/S Ratio: 0.99
• Revenue / Employee: 198,571 EUR
• Employees: 1,575
• Market Cap: 479.94M USD

Revenue Chart

Chart

Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Apr 30, 2026	312.75M	-112.68M	-26.49%
Apr 30, 2025	425.43M	-61.12M	-12.56%
Apr 30, 2024	486.55M	46.77M	10.63%
Apr 30, 2023	439.79M	137.17M	45.33%
Apr 30, 2022	302.62M	41.74M	16.00%
Apr 30, 2021	260.88M	-18.79M	-6.72%
Apr 30, 2020	279.66M	8.02M	2.95%
Apr 30, 2019	271.65M	-	-
Apr 30, 2018	-	-	-
Apr 30, 2017	227.88M	32.89M	16.87%
Apr 30, 2016	194.99M	-9.28M	-4.54%
Apr 30, 2015	204.27M	34.53M	20.34%
Apr 30, 2014	169.74M	6.64M	4.07%
Apr 30, 2013	163.10M	48.08M	41.80%
Apr 30, 2012	115.02M	5.47M	4.99%
Apr 30, 2011	109.55M	51.00K	0.05%
Apr 30, 2010	109.50M	-3.27M	-2.90%
Apr 30, 2009	112.77M	9.34M	9.03%
Apr 30, 2008	103.43M	12.38M	13.59%
Apr 30, 2007	91.05M	14.01M	18.19%
Apr 30, 2006	77.04M	5.05M	7.02%
Apr 30, 2005	71.99M	-	-

Data Source: Fiscal.ai Last updated: Apr 30, 2025

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 3, 2025

Data Sources Report a data error